aTyr Pharma, Inc. (ATYR)
NASDAQ: ATYR · Real-Time Price · USD
5.15
-0.08 (-1.53%)
At close: Aug 13, 2025, 4:00 PM
5.07
-0.08 (-1.55%)
Pre-market: Aug 14, 2025, 9:06 AM EDT
aTyr Pharma Employees
As of December 31, 2024, aTyr Pharma had 65 total employees, including 56 full-time and 9 part-time employees. The number of employees increased by 6 or 10.17% compared to the previous year.
Employees
65
Change (1Y)
6
Growth (1Y)
10.17%
Revenue / Employee
n/a
Profits / Employee
-$1,025,185
Market Cap
504.63M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ATYR News
- 6 days ago - aTyr Pharma Announces Second Quarter 2025 Results and Provides Corporate Update - GlobeNewsWire
- 14 days ago - Insurtech Leader Ethos Adds Industry Veteran William Wheeler to Board of Directors - GlobeNewsWire
- 23 days ago - aTyr Pharma Announces Last Patient Visit in Phase 3 EFZO-FIT™ Study of Efzofitimod in Patients with Pulmonary Sarcoidosis - GlobeNewsWire
- 7 weeks ago - aTyr Pharma to be Added to the Russell 2000® and Russell 3000® Indexes - GlobeNewsWire
- 2 months ago - aTyr Pharma Announces Findings from Interim Analysis of Ongoing Phase 2 EFZO-CONNECT™ Study of Efzofitimod in Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD) - GlobeNewsWire
- 3 months ago - aTyr Pharma to Present at Upcoming Investor Conferences - GlobeNewsWire
- 3 months ago - aTyr Pharma Presents Three Posters on Efzofitimod at the American Thoracic Society (ATS) 2025 International Conference - GlobeNewsWire
- 3 months ago - aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire